Over the past five years, Exact Sciences (NASDAQ: EXAS) hasn't delivered great returns. In fact, the diagnostic testing company has severely underperformed the S&P 500 over this period. Of course, that doesn't mean the company is condemned to do the same over the next half a decade.

But before investing in the stock, you'll want to get a sense of where it might be heading. So can Exact Sciences deliver better returns in the next five years?

Continue reading

Source Fool.com